Redeye comments on ChemoTech’s announcement that a clinical study evaluating its TSE technology for the treatment of equine sarcoids (tumours) will be presented at the upcoming European College of Veterinary Surgeons (ECVS) Annual Scientific Meeting. The study, conducted by Professor Cathrine T. Fjordbakk at the Norwegian University of Life Sciences, assesses treatment outcomes, protocols, and long-term follow-up using the vetIQure™ platform in a clinical setting.
LÄS MER
